Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis

Neurobiology of Disease

Volumn 10, Issue 3, 2002, Pages 268-278

  Kriz, Jasna ^a   Nguyen, Minh Dang ^a   Julien, Jean Pierre ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; INFLAMMATION; LONGEVITY; MICROGLIA; MOUSE; NERVE DEGENERATION; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD;

EID: 0036406903     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0487     Document Type: Article

References (45)

1. Almer, G., Vukosavic, S., Romero, N., & Przedborski, S. (1999) Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 72, 2415-2425.
2. Amin, A. R., Attur, M. G., Thakker, G. D., Patel, P. D., Vyas, P. R., Patel, R. N., Patel, I. R., & Abramson, S. B. (1996) A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases. Proc. Natl. Acad. Sci. USA 93, 14014-14019.
3. Barneoud, P., & Curet, O. (1999) Beneficial effects of lysine acetyl-salicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis. Exp. Neurol. 155, 243-251.
4. Beal, M. F. (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357-366.
5. Bruijn, L. I., Houseweart, M. K., Kato, S., Anderson, K. L., Anderson, S. D., Ohama, E., Reaume, A. G., Scott, R. W., & Cleveland, D. W. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 1851-1854.
6. Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K. B., Zhu, S., Bian, J., Guo, L., Farrellm, L. A., Hersch, S. M., Hobbs, W., Vonsattel, J. P., Cha, J. H., & Friedlander, R. M. (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med. 6, 797-801.
7. Cleveland, D. W. (1999) From Charcot to SOD1: Mechanisms of selective motor neuron death in ALS. Neuron 24, 515-520.
8. Couillard-Després, S., Zhu, Q., Wong, P. C., Price, D. L., Cleveland, D. W., & Julien, J. P. (1998) Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl. Acad. Sci. USA 95, 9626-9630.
9. Cudkowicz, M. E., McKenna-Yasek, D., Sapp, P. E., Chin, W., Geller, B., Hayden, D. L., Schoenfeld, D. A., Hosler, B. A., Horvitz, H. R., & Brown, R. H. (1997) Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 41, 210-221.
10. Estevez, A. G., Crow, J. P., Sampson, J. B., Reiter, C., Zhuang, Y., Richardson, G. J., Tarpey, M. M., Barbeito, L., & Beckman, J. S. (1999) Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286, 2498 -2500.
11. Gabler, W. L., & Creamer, H. R. (1991) Suppression of human neutrophil functions by tetracyclines. J. Periodontal. Res. 26, 52-58.
12. Golub, L. M., Lee, H. M., Ryan, M. E., Giannobile, W. V., Payne, J., & Sorsa, T. (1998) Tetracyclines inhibit connective tissue breakdown by multiple nonantimicrobial mechanisms. Adv. Dent. Res. 12, 12-26.
13. Gottlieb, A. (1997) Safety of minocycline for acne. Lancet 349, 374.
14. Goulden, V., Glass, D., & Cunliffe, W. J. (1996) Safety of long-term high-dose minocycline in the treatment of acne. Br. J. Dermatol. 134, 693-695.
15. Gurney, M. E., Cutting, F. B., Zhai, P., Doble, A., Taylor, C. P., Andrus, P. K., & Hall, E. D. (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147-157.
16. Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H. X., et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775.
17. Hadano, S., Hand, C. K., Osuga, H., Yanagisawa, Y., Otomo, A., Devon, R. S., Miyamoto, N., Showguchi-Miyata, J., Okada, Y., et al. (2001) A gene encoding putative GTPase regulator is mutated in familial amyotrophic sclerosis 2. Nat. Genet. 29, 166-173.
18. Hall, E. D., Oostveen, J. A., & Gurney, M. E. (1998) Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23, 249-256.
19. Hirano, A. (1996) Neuropathology of ALS: an overview. Neurology 47, (Suppl. 2) S63-66.
20. Julien, J.-P. (2001) Amyotrophic lateral sclerosis: Unfolding the toxicity of the misfolded. Cell 104, 581-591.
21. Kawamata, T., Akiyama, H., Yamada, T., & McGeer, P. L. (1992) Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140, 691-707.
22. Klein, N. C., & Cunha, B. A. (1995) Tetracyclines. Med. Clin. North Am. 79, 789-801.
23. Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5, 347-350.
24. Kong, J., & Xu, Z. (1998) Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18, 3241-3250.
25. Leclerc, N., Ribera, F., Zoll, J., Warter, J. M., Poindron, P., Lampert, E., & Borg, J. (2001) Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibers isolated from G93AhumanSOD1 transgenic mice. Neuromuscul. Disord. 11, 722-777.
26. Li, M., Ona, V. O., Guégan, C., Chen, M., Jackson-Lewis, V., An-drews, L. J., Olszewski, A. J., Stieg, P. E., Lee, J. P., Przedborski, S., & Friedlander R. M. (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288, 335-339.
27. McGeer, E. G., & McGeer, P. L. (1999) Brain inflammation in Alzheimer disease and the therapeutic implications. Curr. Pharm. Des. 5, 821-836.
28. Nguyen, M. D., Larivière, R., & Julien, J.-P. (2001) Deregulation of Cdk5 in a mouse model of ALS: Toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30, 135-147.
29. Nguyen, M. D., Julien, J.-P., & Rivest, S. (2002) Innate immunity: The missing link in neuroprotection and neurodegeneration? Nature Rev. Neurosci. 3, 216-227.
30. Pasinelli, P., Houseweart, M. K., Brown, R. H., Jr., & Cleveland, D. W. (2000) Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 97, 13901-13906.
31. Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., & Tsai, L. H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
32. Pramatarova, A., Laganière, J., Roussel, J., Brisebois, K., & Rouleau, G. A. (2001) Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21, 3369-3374.
33. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H. X., et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
34. Rowland, L. P., & Shneider, N. A. (2001) Amyotrophic lateral sclerosis. N. Engl. J. Med. 344, 1688-1700.
35. Sanchez Mejia, R. O., Ona, V. O., Li, M., & Friedlander R. M. (2001) Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48, 1393-1399.
36. Schiffer, D., Cordera, S., Cavalla, P., & Mighelli, A. (1996) Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J. Neurol. Sci. 139, 27-33.
37. Sekizawa, T., Openshaw, H., Ohbo, K., Sugamura, K., Itoyama, Y., & Niland, J. C. (1998) Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: Immunological parameter and comparison with inflammatory and noninflammatory central nervous system diseases. J. Neurol. Sci. 154, 194-199.
38. Tikka, T., Fiebich, B. L., Goldsteins, G., Keinanen, R., & Koistinaho, J. (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21, 2580-2588.
39. Troost, D., Claessen, N., Van den Oord, J. J., Swaab, D. F., & de Jong, J. M. (1993) Neuronophagia in the motor cortex in amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 19, 390-397.
40. Whiteman, M., & Halliwell, B. (1997) Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics. Free Rad. Res. 26, 49-56.
41. Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116.
42. Yang, Y., Hentati, A., Deng, H. X., Dabbagh, O., Sasaki, T., Hirano, M., Hung, W. Y., Ouahchi, K., Yan, J., Azim, A. C., et al. (2001) The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated ina aform of recessive amyotrophic lateral sclerosis. Nat. Genet. 29, 160-165.
43. Yrjänheikki, J., Keinänen, R., Pellikka, M., Hokfelt, T., & Koistinaho, J. (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. USA 95, 15769-15774.
44. Yrjänheikki, J., Tikka, T., Keinänen, R., Goldsteins, G., Chan, P. H., & Koistinaho, J. (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. USA 96, 13496-13500.
45. Zhu, Q., Couillard-Després, S., & Julien, J.-P. (1997) Delayed maturation of regenerating myelinated axons in mice lacking neuro-filaments. Exp. Neurol. 148, 299-316.